Table 3 Change in variables from baseline at 3 months after Roux-en-Y gastric bypass (malabsorptive) and sleeve gastrectomy (restrictive) surgery

BMI (kg/m²)

46.9 ± 10.1

39 ± 8.2

44.8 ± 4.5

36.9 ± 3.9

Glucose (mg/dl)

92.3 ± 22.2

94.5 ± 16

131.1 ± 37.1

104.1 ± 14.8

Insulin (mIU/l)

15.1 (11.8–21.8)

8.3 (4.3–12.0)

19.2 (12.8–27.6)

10.1 (7.5–14.3)

HOMA2- IR

2.3 (1.6–3.0)

1.2 (0.8–1.9)

3.1 (2.1–4.3)

1.5 (1.1–2.2)

NEFA

0.73 ± 0.34

0.78 ± 0.2

0.8 ± 0.35

0.72 ± 0.33

ADIPO-IR

118.2 ± 80.2

92 ± 81.4

107.3 ± 77.6

51.8 ± 9.1

Hb1Ac

6.2 ± 1

5.3 ± 0.94

7.7 ± 2.0

6.2 ± 0.8

Apo A-I (mg/dl)

117.5 ± 21.3

135.5 ± 25.7

103.5 ± 23.1

127.8 ± 18.6

Male

122.3 ± 32.1

133.5 ± 14.0

106.7 ± 13.1

123.3 ± 18.5

Female

111.3 ± 14.8

137.5 ± 28.2

102.8 ± 25.0

126.8 ± 19.0

Apo B (mg/dl)

87.8 ± 20.4

103.8 ± 19.1

75.4 ± 17.0

99.2 ± 16.5

TC (mg/dl)

193.2 ± 80.9

176.8 ± 34.6

163.1 ± 22.9

160.7 ± 22.6

HDL-C (mg/dl)

43.9 ± 11.1

42.3 ± 5.2

42.1 ± 9.3

37 ± 5.9

Male

41.7 ± 8.0

41.3 ± 5.0

39.3 ± 7.3

31.5 ± 4.2

Female

45.5 ± 12.7

42.6 ± 6.0

42.6 ± 9.7

38.2 ± 5.6

LDL-C (mg/dl)

103.5 ± 26.6

116.1 ± 33.0

99.5 ± 26.2

97.5 ± 29.4

TG (mg/dl)

146.9 ± 51.1

116.5 ± 36.9

137.6 ± 35.9

122.1 ± 48.7

VLDL-C (mg/dl)

26.6 ± 11.7

21.9 ± 8.7

24.6 ± 9.3

23.1 ± 9.6

CEC (A.U.)

0.89 ± 0.1

1.03 ± 0.18

0.92 ± 0.14

1.0 ± 0.14

Adiponectin (µg/ml)

6.0 ± 1.3

7.7 ± 1.5

5.4 ± 2.4

6.7 ± 2.7

Log resistin

2.4 ± 0.7

1.9 ± 0.67

2.3 ± 0.16

2.0 ± 0.78

Log MCP-1

1.6 ± 0.4

1.6 ± 0.47

1.9 ± 0.41

1.6 ± 0.53

IL-10 (pg/ml)

0.1 (0.01–0.44)

0.2 (0.12–0.56)

0.33 (0.1–0.8)

0.2 (0.11–0.54)

TNF-alpha (pg/ml)

2 ± 0.8

3 ± 1.4

2.5 ± 2.2

2.2 ± 1.3